OXYTOCIN INHIBITS PROLIFERATION OF HUMAN BREAST-CANCER CELL-LINES

被引：0
|
作者：
CASSONI, P [1 ]
SAPINO, A [1 ]
NEGRO, F [1 ]
BUSSOLATI, G [1 ]
机构：
[1] UNIV TURIN, DEPT BIOMED SCI & ONCOL, I-10126 TURIN, ITALY
来源：
VIRCHOWS ARCHIV | 1994年 / 425卷 / 05期
关键词：
OXYTOCIN; BREAST CANCER; CELL GROWTH;
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
In this study we show that treatment of MDA-MB231 hormone-independent human breast cancer cells with oxytocin (OT) or with the OT analogue F314 induces significant growth inhibition together with a change in cell phenotype. In MCF7 and T47D human breast cancer cells, OT inhibits oestrogen-induced cell growth. In these same cells, OT administration significantly enhances the inhibitory effect of tamoxifen on cell proliferation. MDA-MB231, MCF7 and T47D cells all express mRNA specific for the OT receptor. These data suggest that it may be possible to inhibit breast cancer growth using OT and OT analogues.
引用
收藏
页码：467 / 472
页数：6
相关论文
共 50 条
  • [1] CHLORPHENIRAMINE INHIBITS THE SYNTHESIS OF ORNITHINE DECARBOXYLASE AND THE PROLIFERATION OF HUMAN BREAST-CANCER CELL-LINES
    MEDINA, MA
    DEVEAS, RG
    MORATA, P
    LOZANO, J
    SANCHEZJIMENEZ, F
    BREAST CANCER RESEARCH AND TREATMENT, 1995, 35 (02) : 187 - 194
  • [2] NEW CELL-LINES OF HUMAN BREAST-CANCER ORIGIN
    CALAF, G
    ABARCAQUINONES, J
    FEUILHADE, F
    BEAUNE, J
    DUPRE, G
    ORRICO, M
    BARNABASSOHI, N
    KOUYOUMDJIAN, JC
    BREAST CANCER RESEARCH AND TREATMENT, 1992, 21 (01) : 63 - 75
  • [3] DIFFERENTIATION STATE AND INVASIVENESS OF HUMAN BREAST-CANCER CELL-LINES
    SOMMERS, CL
    BYERS, SW
    THOMPSON, EW
    TORRI, JA
    GELMANN, EP
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 31 (2-3) : 325 - 335
  • [4] MODULATION OF PROLIFERATION AND CELL-SURFACE MARKERS OF BREAST-CANCER CELL-LINES BY RETINOIDS
    WALKER, RA
    GARDNER, FJE
    JOURNAL OF PATHOLOGY, 1991, 163 (02): : A180 - A180
  • [5] COMBINED EFFECTS OF LONIDAMINE AND TAMOXIFEN IN HUMAN BREAST-CANCER CELL-LINES
    GORNATI, D
    ZAFFARONI, N
    ORLANDI, L
    DIFRONZO, G
    SILVESTRINI, R
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 6 (05) : 993 - 996
  • [6] MECHANISMS OF RESISTANCE TO ANSAMYCIN ANTIBIOTICS IN HUMAN BREAST-CANCER CELL-LINES
    BENCHEKROUN, MN
    SCHNEIDER, E
    SAFA, AR
    TOWNSEND, AJ
    SINHA, BK
    MOLECULAR PHARMACOLOGY, 1994, 46 (04) : 677 - 684
  • [7] REGULATION OF VIMENTIN GENE-TRANSCRIPTION IN HUMAN BREAST-CANCER CELL-LINES
    SOMMERS, CL
    SKERKER, JM
    CHRYSOGELOS, SA
    BOSSELER, M
    GELMANN, EP
    CELL GROWTH & DIFFERENTIATION, 1994, 5 (08): : 839 - 846
  • [8] GLUTATHIONE DEPLETION IN HUMAN AND IN RAT MULTIDRUG RESISTANT BREAST-CANCER CELL-LINES
    BATIST, G
    SCHECTER, R
    WOO, A
    GREENE, D
    LEHNERT, S
    BIOCHEMICAL PHARMACOLOGY, 1991, 41 (04) : 631 - 635
  • [9] IGFS AND IGF BINDING-PROTEINS IN HUMAN BREAST-CANCER CELL-LINES
    WILSON, DM
    DELEON, DD
    BAKKER, B
    LAMSON, G
    ROSENFELD, RG
    INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS, 1989, 881 : 241 - 247
  • [10] 1-ALPHA-25-DIHYDROXYCHOLECALCIFEROL AND HUMAN BREAST-CANCER CELL-LINES
    DEGREMOUX, P
    CALVO, F
    GAUVILLE, C
    JABRANE, N
    ABITA, JP
    LAGIER, G
    LECHAT, P
    THERAPIE, 1987, 42 (03): : 327 - 327
12345